Omega-3 Aspirin Trial for Periodontitis
Analysis based on 6 articles · First reported Aug 11, 2026 · Last updated Sep 04, 2026
The trial could influence periodontal treatment protocols and reduce antibiotic use, potentially impacting pharmaceutical sales of amoxicillin and metronidazole. It may also boost interest in omega-3 and aspirin combination therapies, though clinical adoption is years away pending further trials.
A randomized controlled trial published in the Journal of Periodontology found that a combination of omega-3 fatty acids and low-dose aspirin was nearly as effective as antibiotics (amoxicillin and metronidazole) in treating severe periodontitis. The study, conducted by researchers from Albert Einstein Israelite Hospital, Guarulhos University, University of Taubate, University of São Paulo, and Harvard University, enrolled 109 patients with advanced gum disease. All received standard deep cleaning, then were divided into four groups: placebo, antibiotics for 14 days, omega-3 plus aspirin for six months, or both. After one year, 58% of the antibiotic group and 57.7% of the omega-3/aspirin group achieved the clinical target of no more than four deep pockets, compared to only 23.1% in the placebo group. Combining both treatments provided no additional benefit. The benefits persisted six months after stopping supplements. The findings suggest a potential antibiotic-sparing alternative, especially for patients who cannot tolerate antibiotics. However, researchers caution that this is a single small trial and not yet a routine replacement. Aspirin carries bleeding risks, and larger studies in diverse populations are needed.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard